BN.com Gift Guide

Approved New Drugs / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $25.12
Usually ships in 1-2 business days
(Save 83%)
Other sellers (Hardcover)
  • All (2) from $25.12   
  • New (1) from $40.50   
  • Used (1) from $25.12   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$40.50
Seller since 2005

Feedback rating:

(332)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
2002 Hardcover New

Ships from: Portland, OR

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

This publication is the first of a series of annual reference works covering drugs that have received regulatory approval during the previous year. This first volume, New Drugs 2001 contains descriptions of the more than 100 new drugs from 30 therapeutic categories that have been approved (or approved for major new uses) in the last several years. A brief introduction to each class of drugs provides highlights of recent developments in drug development and marketing for the corresponding disease category. The chemical, physical and pharmacological properties of each agent are recorded along with the chemical structure, registry numbers and an exhaustive listing of product trade names and manufacturers. Each record includes useful patent information and a history of the agent's regulatory approval. A comprehensive Subject and Synonym Index along with CAS Registry Number and EINECS number indexes provide useful entry points to the data. An extensive Manufacturer Directory provides convenient contact information.
Read More Show Less

Editorial Reviews

Library Journal
This guide, the first in an annual series, describes all new drugs approved by the Food and Drug Administration (FDA) since January 1, 2000. Each entry includes the drug's synonyms and trade names, the CAS Registry Number, physical properties, manufacturer, and patent and regulatory information. However, there is no information on the drug's therapeutic use. In pre-Internet days, this book would have been useful, but now it is unlikely that most academic and medical libraries will have $90 to buy a reference for information easily found for free online on the FDA's web site and other resources. Details on drug properties can be found quickly in the Merck Index or in Drugs: Synonyms & Properties, also edited by Milne, although the newest pharmaceuticals will not be included. Manufacturer information can be found in almost all drug guides, including the Physicians Desk ReferenceR, and patent information is available from the U.S. Patent and Trademark Office's Web Patent Database. Still, this volume does offer a concise summary of new developments in drug research. And having all of a substance's chemical information in one place can save a researcher time, making this book useful for corporate libraries that can afford it.-Natalie Kupferberg, Biological Sciences/Pharmacy Lib., Ohio State Univ. Lib., Columbus Copyright 2002 Cahners Business Information.
From The Critics
Initiating a new annual series, this volume provides information for physicians and drug designers concerning drugs that were newly approved (or approved for major new uses) in the years named in the title (2000 and 2001). Identified here are 50 drugs recently approved as "New Molecular Entities" by the US Food and Drug Administration, and an additional 129 drugs relevant to these new NMEs. The introduction briefly outlines some of the social and scientific context relevant to the development and marketing of each type of drug. Entries are organized according to 30 therapeutic classes (e.g. antiasthma agents, antifungals, cardioactive agents, sedatives, vasodilators, etc.) and include (as available) chemical, physical and pharmacological properties, chemical structures, trade and generic names, patent information and regulatory approval history, CAS and EINECS numbers, and manufacturer and supplier information. Annotation c. Book News, Inc., Portland, OR
Read More Show Less

Product Details

  • ISBN-13: 9780566085161
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 7/24/2002
  • Edition number: 1
  • Pages: 168
  • Product dimensions: 7.05 (w) x 10.08 (h) x 0.76 (d)

Meet the Author

G W A Milne was a Senior Researcher at the National Institutes of Health in Bethesda, MD, USA for 35 years where he worked on the use of spectroscopy for structure determination of organic compounds, and on molecular modeling in the design of drugs for the treatment of cancer and AIDS. From 1980 until 1998 he worked in molecular modeling and information technology at the National Cancer Institute, one of the NIH Institutes. He has been active for many years in the fields of chemical information and chemical computation and is the Editor of the American Chemical Society's Journal of Chemical Information and Computer Science and Gardner's Chemical Synonyms and Trade Names, Eleventh Edition (Ashgate).
Read More Show Less

Table of Contents

Preface.

How to Use This Book.

Glossary of Units.

Glossary of Terms.

Abbreviations and Symbols.

Introduction.

Introduction.

US FDA 2000 Approvals.

US FDA 2001 Approvals.

Drug Entries.

ACE inhibitors.

Anesthetics.

Antiallergy Agents.

Antiasthma Agents.

Antibiotics.

Anti-BPH Agents.

Antidiabetics.

Antiemetics.

Antifungals.

Antihyperlipoproteinemics.

Antihypertensives.

Antihyperthyroids.

Anti-inflammatories.

Antineoplastics.

Antiobesity Agents.

Antithrombotics.

Antivirals.

Cardioactive Agents.

Cerebrally Active Agents.

Contraceptives.

Diagnostic Agents.

Gastric Secretion Inhibitors, Antiulceratives.

Hematinics.

Hemostatics.

Immunosuppressants.

Keratolytics.

Muscle Relaxants.

Ophthalmologic Drugs.

Pulmonary Surfactants.

Sedatives.

Topical Protectants.

Vasodilators.

Indexes.

CAS Registry Number Index.

EINECS Number Index.

Subject and Synonym Index.

Manufacturer Directory.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)